Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial
- 1 May 2009
- journal article
- research article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 20 (5), 935-940
- https://doi.org/10.1093/annonc/mdn701
Abstract
Background: Central venous access is extensively used in oncology, though practical information from randomized trials on the most convenient insertion modality and site is unavailable. Methods: Four hundred and three patients eligible for receiving i.v. chemotherapy for solid tumors were randomly assigned to implantation of a single type of port (Bard Port™, Bard Inc., Salt Lake City, UT), through a percutaneous landmark access to the internal jugular, a ultrasound (US)-guided access to the subclavian or a surgical cut-down access through the cephalic vein at the deltoid–pectoralis groove. Early and late complications were prospectively recorded until removal of the device, patient's death or ending of the study. Results: Four hundred and one patients (99.9%) were assessable: 132 with the internal jugular, 136 with the subclavian and 133 with the cephalic vein access. The median follow-up was 356.5 days (range 0–1087). No differences were found for early complication rate in the three groups {internal jugular: 0% [95% confidence interval (CI) 0.0% to 2.7%], subclavian: 0% (95% CI 0.0% to 2.7%), cephalic: 1.5% (95% CI 0.1% to 5.3%)}. US-guided subclavian insertion site had significantly lower failures (e.g. failed attempts to place the catheter in agreement with the original arm of randomization, P = 0.001). Infections occurred in one, three and one patients (internal jugular, subclavian and cephalic access, respectively, P = 0.464), whereas venous thrombosis was observed in 15, 8 and 11 patients (P = 0.272). Conclusions: Central venous insertion modality and sites had no impact on either early or late complication rates, but US-guided subclavian insertion showed the lowest proportion of failures.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
This publication has 36 references indexed in Scilit:
- Thromboprophylaxis in cancer patients with central venous cathetersThrombosis and Haemostasis, 2008
- Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trialsStatistics in Medicine, 2005
- External Jugular Vein Cutdown Approach, as a Useful Alternative, Supports the Choice of the Cephalic Vein for Totally Implantable Access Device PlacementAnnals of Surgical Oncology, 2005
- Ultrasound for central venous cannulation: economic evaluation of cost‐effectivenessAnaesthesia, 2004
- Ultrasonic locating devices for central venous cannulation: meta-analysisBMJ, 2003
- Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of deviceBone Marrow Transplantation, 1999
- Long-term, totally implantable central venous access ports connected to a Groshong atheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of deviceEuropean Journal of Cancer, 1997
- Ultrasound guidance for placement of central venous cathetersCritical Care Medicine, 1996
- Subclavian venous catheterizationCritical Care Medicine, 1995